RANI Profile
Rani Therapeutics Holdings, Inc. is a clinical-stage biotechnology company focused on revolutionizing the delivery of biologic therapies through oral administration. The company is pioneering the development of its proprietary RaniPill platform, designed to replace traditional subcutaneous or intravenous injections with a more patient-friendly oral dosing method. This innovative approach aims to enhance patient compliance and comfort while broadening the accessibility of biologic treatments.
The RaniPill platform encapsulates biologics in a unique oral capsule that protects the therapeutic agents from the digestive tract, allowing them to be effectively absorbed in the gastrointestinal system. This technology is currently advancing through various stages of clinical and preclinical development. Among its notable pipeline products, RT-101, an octreotide formulation, has completed Phase I clinical trials for treating neuroendocrine tumors and acromegaly. RT-105, an anti-TNF-alpha antibody, is being developed to address psoriatic arthritis, while RT-102, a parathyroid hormone product, is in preclinical studies targeting osteoporosis.
Additionally, Rani Therapeutics is advancing RT-109, a human growth hormone aimed at treating growth hormone deficiency, and RT-110, another parathyroid hormone intended for the treatment of hypoparathyroidism. RT-106, a basal insulin formulation, is being developed for managing type 2 diabetes. These products represent a broad and diverse pipeline that reflects the company's commitment to addressing a wide range of serious medical conditions through its innovative oral delivery technology.
Founded in 2012 and headquartered in San Jose, California, Rani Therapeutics Holdings, Inc. continues to drive forward with its mission to transform biologic drug delivery. The company's focus on oral administration aligns with its goal to improve patient experiences and expand the therapeutic potential of biologics, making advanced treatments more accessible and convenient for patients worldwide.
|
